In this issue:
Māori and Pacific smokers’ views on informed choice and smoking
E-cigarettes and smoking cessation
Healthcare providers and smoking cessation among smokers ±COPD
Fluticasone furoate/vilanterol in COPD with increased CV risk
Comparisons of long-acting inhaled agents for COPD
ICS discontinuation in COPD and pneumonia risk
Indacaterol/glycopyrronium vs. salmeterol/fluticasone for COPD
Eosinophil count and COPD exacerbations after ICS withdrawal
Lung deflation and CV structure/ function in COPD
β-blockers reduce COPD exacerbations
Endobronchial valves for emphysema without interlobar collateral ventilation
Psychological disorders and readmission in COPD
Please login below to download this issue (PDF)